Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 15.1B | 13.9B | 12.7B | 12.7B |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 5.0B | 3.9B | 4.3B | 4.4B |
Other operating expenses | — | — | — | — |
Operating income | — | — | — | — |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 5.6B | 5.3B | 4.0B | 3.9B |
Tax provision | 909M | 1.1B | 997M | 873M |
Net income | 4.7B | 4.1B | 3.0B | 3.0B |
Basic EPS | 14.3 | 12.1 | 8.5 | 8.7 |
Diluted EPS | 14.1 | 12.0 | 8.4 | 8.6 |
Basic average shares | 320.8M | 322.4M | 324.8M | 329.8M |
Diluted average shares | 324.5M | 328.4M | 330.8M | 335.5M |
EBITDA | — | — | — | — |
Net income from continuing op. | 4.7B | 4.1B | 3.0B | 3.0B |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |